Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 20/20 | 0.80 |
| ▸ | PDE4B | Q07343 | 20/20 | 0.80 |
| ▸ | PDE4C | Q08493 | 20/20 | 0.80 |
| ▸ | PDE4D | Q08499 | 20/20 | 0.80 |
| ▸ | PDE3B | Q13370 | 13/20 | 0.74 |
| ▸ | PDE3A | Q14432 | 13/20 | 0.74 |
| ▸ | PDE5A | O76074 | 10/20 | 0.60 |
| ▸ | PDE1A | P54750 | 10/20 | 0.60 |
| ▸ | PDE1B | Q01064 | 10/20 | 0.60 |
| ▸ | PDE1C | Q14123 | 10/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6990758 | 1.00 | PDE4A (0.80) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL6990755 | 1.00 | PDE4A (0.80) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL6623347 | 0.91 | PDE4A (0.73) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL6994103 | 0.89 | PDE4A (0.73) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL6994109 | 0.89 | PDE4A (0.73) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL8413178 | 0.89 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL7821995 | 0.89 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL6623738 | 0.87 | PDE4A (0.74) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL6998629 | 0.85 | PDE4A (0.81) | PDE4APDE4BPDE4CPDE4DPDE3B | |
| SCHEMBL6998626 | 0.85 | PDE4A (0.81) | PDE4APDE4BPDE4CPDE4DPDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0980374-B1 | PHOSPHODIESTERASE 4-INHIBITING DIAZEPINOINDOLONES | PFIZER HOLDING FRANCE (FR) | 2003-02-12 | — | — | EP | disclosed |
| US-6239130-B1 | ASTHMA, ATOPIC DERMATITIS, RHEUMATOID ARTHRITIS, INFLAMMATORY BOWEL DISORDERS, PULMONARY HYPERTENSION, LIVER INJURY, BONE LOSS, SEPTIC SHOCK, OR MULTIPLE SCLEROSIS, | WARNER-LAMBERT COMPANY | 2001-05-29 | — | — | US | disclosed |